NexImmune, Inc.
Developing T cell immunotherapies
- Publicly traded
- Pharma & life sciences
About NexImmune, Inc.
A clinical-stage biotech company developing T cell immunotherapies using proprietary AIM technology, with a focus on treating AML and multiple myeloma
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Gaithersburg, Maryland, United States
- Founded
- 2011
- Revenue
- $9.6M – $75.7MTamtam estimate
- Website
- neximmune.com
NexImmune, Inc. at a glance
NexImmune, Inc. is a company in the Biotechnology Research industry, headquartered in Gaithersburg, Maryland, United States.
NexImmune, Inc. was founded in 2011.
NexImmune, Inc. has 11–50 employees.
NexImmune, Inc.'s revenue is $9.6M – $75.7M (Tamtam estimate).
Frequently asked questions about NexImmune, Inc.
What is NexImmune, Inc.'s revenue?
Tamtam estimates NexImmune, Inc.'s annual revenue at $9.6M – $75.7M.
How many employees does NexImmune, Inc. have?
NexImmune, Inc. has 11–50 employees.
Where is NexImmune, Inc. headquartered?
NexImmune, Inc. is headquartered in Gaithersburg, Maryland, United States.
Selling to companies like NexImmune, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies